Acumen Pharmaceuticals, Inc. (ABOS) stock
ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.21−0.00 (-1.83%)
Close on Nov 13, 2026Market cap $15.48MP/E –Yield –
Acumen Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Acumen Pharmaceuticals's enterprise value was -$73.89M on Nov 11, 2026, against -$9.36M a year earlier. Over the last 5 years it ranged from -$111.71M to $216.32M, with a median of -$9.22M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$73.89M | -1718.0% |
| 2025 | Dec 31, 2025 | $4.57M | – |
| 2024 | Dec 31, 2024 | -$97.24M | -1539.9% |
| 2023 | Dec 29, 2023 | $6.75M | -63.5% |
| 2022 | Dec 30, 2022 | $18.52M | -74.8% |
| 2021 | Dec 31, 2021 | $73.62M | – |
See a number that looks wrong?